Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPM.L Regulatory News (JPM)

  • There is currently no data for JPM

Stabilisation Notice

25 Apr 2016 13:27

RNS Number : 2354W
J.P. Morgan Securities PLC.
25 April 2016
 

25th April 2016

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

JPMorgan Chase & Co

Stabilisation Notice

JPMorgan Securities Limited, (contact: Emma Lovett 0207 134 2468) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

JPMorgan Chase & Co 

Aggregate nominal amount:

EUR [TBA]

Description:

Senior unsecured 10.5yr, REG S Registered

Offer price:

[TBA]

Other offer terms:

London Listing

 

Stabilisation:

Stabilising Manager(s):

JPM

 

Stabilisation period expected to start on:

25th April 2016

Stabilisation period expected to end no later than:

25th May 2016

Maximum size of over-allotment facility:

5% of the aggregate nominal amount stated above.

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) or persons acting on behalf of the Stabilisation Manager(s) will take any stabilisation action. Stabilisation action may begin on or after the date on which adequate public disclosure of the final terms of the offer is made and, if begun, may be ended at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAEAALSAALKEFF
Date   Source Headline
24th Apr 20175:30 pmRNSHolding(s) in Company
21st Apr 20177:00 amRNSDirector/PDMR Shareholding
20th Apr 20175:20 pmRNSHolding(s) in Company
20th Apr 201710:00 amBUSJPMorgan Chase Commits $8.6 Million to Fill Well-Paying, High-Demand Healthcare Jobs
20th Apr 20177:00 amRNSDirector/PDMR Shareholding
19th Apr 20175:20 pmRNSHolding(s) in Company
19th Apr 201711:15 amRNSHolding(s) in Company
18th Apr 20175:53 pmRNSPublication of Supplementary Prospectus
18th Apr 20175:04 pmRNSHolding(s) in Company
18th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20177:00 amBUSJPMorgan Chase Declares Preferred Stock Dividend
13th Apr 20174:41 pmRNSJPMC&Co. Form 8-K dated Apr 13, 2017 (1Q presentn)
13th Apr 201712:02 pmRNSJPMC&Co. Form 8-K dated Apr 13, 2017 (1Q earnings)
13th Apr 201711:53 amBUSJPMorgan Chase Reports First-Quarter 2017 Financial Results
12th Apr 20179:14 amRNSNotice of Amendment
12th Apr 20179:08 amRNSNotice of Amendment
12th Apr 20179:03 amRNSNotice of Amendment
11th Apr 20177:00 amRNSDirector/PDMR Shareholding
7th Apr 20177:00 amRNSJPMC&Co. 2017 Proxy Statement
6th Apr 20177:00 amRNSDirector/PDMR Shareholding
6th Apr 20177:00 amBUSJPMorgan Chase 2017 Proxy Statement
5th Apr 20177:00 amBUSJPMorgan Chase Announces Adjustment to Warrant Exercise Price
4th Apr 20175:17 pmBUSJPMorgan Chase 2016 Annual Report
4th Apr 201710:09 amRNSHolding(s) in Company
3rd Apr 20175:01 pmBUSJPMorgan Chase First-Quarter 2017 Earnings
29th Mar 20175:19 pmBUSCity First Enterprises and 11th Street Bridge Park Receive $250,000 Investment from JPMorgan Chase & Co.
23rd Mar 20177:00 amRNSHolding(s) in Company
22nd Mar 20174:56 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSDividend Declaration
22nd Mar 20177:00 amBUSJPMorgan Chase Declares Common Stock Dividend
21st Mar 20178:29 amRNSHolding(s) in Company
16th Mar 20172:47 pmBUSMacomb Innovation Fund Awards $75,000 to Three Detroit-Area Technology Startups
16th Mar 20171:42 pmRNSAmendment Notice
16th Mar 20171:38 pmRNSAmendment Notice
16th Mar 20171:37 pmRNSAmendment Notice
16th Mar 20171:30 pmRNSAmendment Notice
16th Mar 20171:29 pmRNSAmendment Notice
16th Mar 20171:25 pmRNSAmendment Notice
16th Mar 20179:24 amRNSHolding(s) in Company
16th Mar 20177:00 amBUSJPMorgan Chase Declares Preferred Stock Dividend
7th Mar 20177:00 amRNSRedemption Notice Notes due 2037 (XS0295264948)
3rd Mar 20177:00 amRNSDirector/PDMR Shareholding
1st Mar 20176:10 pmRNSPublication of Supplementary Prospectus
1st Mar 20177:00 amRNSJPMC&Co. Form 10-K;JPMCB 2016 Financial Statements
28th Feb 201711:56 amBUSJPMorgan Chase 2017 Investor Day
23rd Feb 201711:00 amBUSJPMorgan Chase Commits More Than $1.2 Million to Help Revitalize Detroit’s Neighborhoods
23rd Feb 20179:36 amRNSHolding(s) in Company
16th Feb 20177:00 amRNSDirector/PDMR Shareholding
14th Feb 20177:00 amBUSJPMorgan Chase Declares Preferred Stock Dividend
7th Feb 20174:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.